Major finding provides mechanistic explanation for ibezapolstat\'s (IBZ) selectivity in that the predicted bactericidal interaction between IBZ and its target DNA pol IIIC is conserved across most of
Zhou Cheng: A Pioneer and Leader in China's Mobile Health Field——The Innovative Journey from Hi-Tech Wealth to Redbird Mobile
BANGKOK,Feb. 20,2025-- King Chulalongkorn Memorial HospitalandThai Red Cross Societyhavelaunched the "Check PD" application for Parkinson\'s risk screeningafter statistics show that the dise
SYDNEY,Feb. 20,2025-- Silicon Quantum Computing (SQC),a pioneer in quantum computing and atomic manufacturing,today announced that it has demonstrated world-leading accuracy in the operation of Grove
20 scholarships annually to enable financially challenged students to pursue transformative learning experiences through international student exchange programmes
NEW YORK,Feb. 20,2025-- Hong KongPharma Digital Technology Holdings Limited has recently signed a cooperation agreement with a leading technology-driven e-commerce platform serving hundreds of million
HONG KONG,Feb. 20,2025-- Euro Tech Holdings Company Limited (Nasdaq: CLWT) (the "Company") today announced that its Board of Directors (the "Board") has approved a program to repur
CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SHANGHAI,Feb. 20,2025-- Harbour BioMed (HKEX: 02142,the "Company"),a global biopharmaceutical company committed to the discovery,development and co
STEINHAGEN,Germany,Feb. 20,2025-- Plasmatreat,a leading company in the field of surface treatment with plasma technology,developed the REDOX-Tool: an environmentally friendly,chemical-free solution f
YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1
© OfficialAffairs
